Evotec SE (EVO) Other financing activities (2010 - 2026)
Evotec SE (EVO) reported Other financing activities of $115.9 for Q1 2026, down 47.53% on a YoY basis from $220.9 in Q1 2025, and down 47.53% sequentially from $220.9 in Q1 2025.
Evotec SE (EVO) Other financing activities (2010 - 2026) Analysis & Trends
Evotec SE (EVO) has 6 years of Other financing activities data on file, last reported at $115.9 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 47.53% year-over-year to $115.9; the trailing twelve-month figure through Mar 2026 stood at $733.32 (up 18.97% YoY), and the FY2009 full-year result was $387796.0, changed N/A from the prior year.
- Other financing activities slipped to $115.9 in Q1 2026, from $220.9 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $396.52 in Q1 2024 to a low of -$1.01 in Q3 2022.
- A 4-year average of $223.9 and a median of $220.9 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities plunged 100.17% in 2022 and plunged 44.29% in 2025, its largest moves.
- Tracing EVO's Other financing activities over 4 years: stood at -$1.01 in 2022, then soared by 39426.8% to $396.52 in 2024, then sank by 44.29% to $220.9 in 2025, then tumbled by 47.53% to $115.9 in 2026.
- Business Quant data shows EVO's Other financing activities at $115.9 in Q1 2026, $220.9 in Q1 2025, and $396.52 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115.90 |
| Mar 31, 2026 | 115.90 |
| Mar 31, 2025 | 220.90 |
| Mar 31, 2025 | 220.90 |
| Mar 31, 2024 | 396.52 |
| Mar 31, 2024 | 396.52 |
| Sep 30, 2022 | -1.01 |
| Sep 30, 2022 | -1.01 |
| Mar 31, 2022 | 387.21 |
| Mar 31, 2022 | 387.21 |
| Sep 30, 2021 | 593.18 |
| Sep 30, 2021 | 593.18 |
| Jun 30, 2021 | 56.60 |
| Jun 30, 2021 | 56.60 |
| Mar 31, 2021 | 779.23 |
| Mar 31, 2021 | 779.23 |
| Sep 30, 2010 | 18.08 |
| Sep 30, 2010 | 18.08 |
| Jun 30, 2010 | 193.78 |
| Jun 30, 2010 | 193.78 |